A brief history of anti-VEGF for the treatment of ocular angiogenesis.
about
Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal MiceImatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cellsIdentification of a stable molecular signature in mammary tumor endothelial cells that persists in vitro.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationNanoengineering of therapeutics for retinal vascular disease.Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex VivoThe regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.New Insights into the Function of the Matricellular CCN1: an Emerging Target in Proliferative Retinopathies.How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review.Advances in our understanding of diabetic retinopathy.In vitro and ex vivo retina angiogenesis assays.The role of vascular endothelial growth factor and vascular stability in diseases of the ear.A safety evaluation of ranibizumab in the treatment of age-related macular degeneration.Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study.Differential effects of bevacizumab, ranibizumab and aflibercept on cell viability, phagocytosis and mitochondrial bioenergetics of retinal pigment epithelial cell.Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.EDIL3 knockdown inhibits retinal angiogenesis through the induction of cell cycle arrest in vitro.Relationship between Pericytes and Endothelial Cells in Retinal Neovascularization: A Histological and Immunofluorescent Study of Retinal Angiogenesis.Introduction of a nurse-led intravitreal injection service in ophthalmology.Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy.Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis.Painful Understanding of VEGF
P2860
Q27301339-07B3583E-6595-4A0E-ABF1-9CDB035F6B59Q30579734-7E409DAE-8408-4E0F-8E89-782011B83499Q33645711-4D653F90-28FE-4773-B025-D8F6BAA2F0ABQ35224472-7DB6AB17-498B-4A79-B276-7118ABBD0FADQ35645705-2BC92CF9-6E6D-4FEA-A140-0BA9FE10B526Q35830423-81C0391C-E39B-410B-A775-B5D874ED4C0BQ36828146-B2A5E2B2-65BB-41F4-94E8-1FA08EE1C6A3Q36953658-1BC7BB09-FA92-4364-812B-76AFDA543A01Q37517122-9C38E03C-E12B-4295-80DF-C7CECD6F91CAQ38088818-7AF85A72-F867-4455-97EA-5CD6B962D6A9Q38152261-4E0A23B6-7492-437E-81D5-DD8C3C34ABEBQ38172070-EB01C45F-D54D-4078-BC63-C1CF50B056EDQ38236770-BB42E1B7-F5CF-4BE9-B600-B41B64755285Q38618655-5829C409-26E5-4240-95E4-64FDB2DB6B0BQ38874774-333E7E7E-A28C-4318-8D77-E0D7DB9253B3Q38882106-E9B5E432-A29F-47C8-A8EB-63632B98A2B4Q41625930-53160696-EF5B-4E07-ACDA-31111F46A6C9Q41899475-4FEF42FE-3A63-4AAC-BEE6-823C3BA2DC6AQ42363696-75F46C04-D173-409D-B4A6-1241E76AC2EDQ42679433-F463BE3D-66F5-41AE-A8DE-C719591CB2F9Q47708166-D7C85043-5766-4495-A364-CDE05D7CD948Q48025665-5257F696-C455-475A-BAB1-4BE417BDE94AQ48227262-88047A17-F695-4161-AE18-2C556DA067BEQ48349526-5573C18A-E8D9-4288-8EAA-FAAA41171766Q51063080-57E769E4-CC8F-4C3B-BA74-44AFD6CA2E01Q59128370-0F58E58E-BDAE-491D-BAA7-18403D69DD7F
P2860
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
@en
type
label
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
@en
prefLabel
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
@en
P2860
P1476
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
@en
P2093
P2860
P304
P356
10.1016/J.AJPATH.2012.06.006
P407
P577
2012-06-29T00:00:00Z